Peter Barton Hutt

Insider Reports History

Entity
Individual
Signature
/s/ Jeffrey A. Munsie, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Barton Hutt:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CONCERT PHARMACEUTICALS, INC. Director Common Stock 0 $8.33 Mar 6, 2023 Direct
CONCERT PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 0 Mar 6, 2023 Direct

Insider Reports Filed by Peter Barton Hutt

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CNCE CONCERT PHARMACEUTICALS, INC. Mar 6, 2023 9 $0 4 Mar 6, 2023 Director
CNCE CONCERT PHARMACEUTICALS, INC. Oct 14, 2022 3 -$11.4K 4 Oct 18, 2022 Director
CNCE CONCERT PHARMACEUTICALS, INC. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
CNCE CONCERT PHARMACEUTICALS, INC. Jun 10, 2021 2 $0 4 Jun 11, 2021 Director